Recently, studies have showed that AKT can regulate the PR-dependent transcription and angiogenesis, and progestin resistance can be reversed by inhibiting the PI3K/AKT pathway in endometrial cancer (7, 29). The gene discussed is AKT1; the disease is endometrial cancer.